QALWQuality-Adjusted Life Week (clinical trials)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
In comparison to anticancer drugs other than doxorubicin, PLD has a higher efficacy and cost than gemcitabine, the incremental cost-effectiveness ratio (ICER) observed for PLD was between 170 [euro] and 318 [euro] per QALW, which is between 8864 [euro] and 16581 [euro] per quality-adjusted life year (QALY) gained.
(23) Costs and QALWs PLD has a higher drug cost than gemcitabine.